Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason B Harris

Showing results (161-170 of 181) with videos related to

Pageof 19
Sort By:
Msphere|July 7, 2021
Defining Polysaccharide-Specific Antibody Targets against Vibrio cholerae O139 in Humans following O139 Cholera and following Vaccination with a Commercial Bivalent Oral Cholera Vaccine, and Evaluation of Conjugate Vaccines Targeting O139Mohammad Kamruzzaman, Meagan Kelly, Richelle C Charles, et al.
Mbio|October 26, 2022
Identifying Recent Cholera Infections Using a Multiplex Bead Serological AssayForrest K Jones, Taufiqur R Bhuiyan, Rachel E Muise, et al.
Nature Communications|December 12, 2025
Gut bacteria-derived sphingolipids alter innate immune responses to oral cholera vaccine antigensDenise Chac, Frederick J Heller, Hasan Al Banna, et al.
Mbio|September 12, 2025
Human antibody targeting <i>Vibrio cholerae</i> O1 O-specific polysaccharide induces an amotile hypovirulent bacterial phenotype: mechanism of protection against choleraSmriti Verma, Murat Cetinbas, Meagan Kelly, et al.
The American Journal of Tropical Medicine and Hygiene|April 2, 2014
Immune responses to O-specific polysaccharide and lipopolysaccharide of Vibrio cholerae O1 Ogawa in adult Bangladeshi recipients of an oral killed cholera vaccine and comparison to responses in patients with choleraTaher Uddin, Amena Aktar, Peng Xu, et al.
Plos Neglected Tropical Diseases|November 20, 2019
Immune responses to O-specific polysaccharide (OSP) in North American adults infected with Vibrio cholerae O1 InabaMotaher Hossain, Kamrul Islam, Meagan Kelly, et al.
Emerging Infectious Diseases|May 20, 2021
Seroprevalence of Severe Acute Respiratory Syndrome Coronavirus 2 IgG in Juba, South Sudan, 2020<sup>1</sup>Kirsten E Wiens, Pinyi Nyimol Mawien, John Rumunu, et al.
Mbio|December 22, 2016
Single-Cell Analysis of the Plasmablast Response to Vibrio cholerae Demonstrates Expansion of Cross-Reactive Memory B CellsRobert C Kauffman, Taufiqur R Bhuiyan, Rie Nakajima, et al.
Medrxiv : the Preprint Server for Health Sciences|March 24, 2021
Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Juba, South Sudan: a population-based studyKirsten E Wiens, Pinyi Nyimol Mawien, John Rumunu, et al.
IJID Regions|June 20, 2022
Seroprevalence of SARS-CoV-2 antibodies in Bangladesh related to novel coronavirus infectionTaufiqur Rahman Bhuiyan, Marjahan Akhtar, Aklima Akter, et al.
Pageof 19

Showing results (161-170 of 181) with videos related to

Sort By:
Pageof 19
Msphere|July 7, 2021
Defining Polysaccharide-Specific Antibody Targets against Vibrio cholerae O139 in Humans following O139 Cholera and following Vaccination with a Commercial Bivalent Oral Cholera Vaccine, and Evaluation of Conjugate Vaccines Targeting O139Mohammad Kamruzzaman, Meagan Kelly, Richelle C Charles, et al.
Mbio|October 26, 2022
Identifying Recent Cholera Infections Using a Multiplex Bead Serological AssayForrest K Jones, Taufiqur R Bhuiyan, Rachel E Muise, et al.
Nature Communications|December 12, 2025
Gut bacteria-derived sphingolipids alter innate immune responses to oral cholera vaccine antigensDenise Chac, Frederick J Heller, Hasan Al Banna, et al.
Mbio|September 12, 2025
Human antibody targeting <i>Vibrio cholerae</i> O1 O-specific polysaccharide induces an amotile hypovirulent bacterial phenotype: mechanism of protection against choleraSmriti Verma, Murat Cetinbas, Meagan Kelly, et al.
The American Journal of Tropical Medicine and Hygiene|April 2, 2014
Immune responses to O-specific polysaccharide and lipopolysaccharide of Vibrio cholerae O1 Ogawa in adult Bangladeshi recipients of an oral killed cholera vaccine and comparison to responses in patients with choleraTaher Uddin, Amena Aktar, Peng Xu, et al.
Plos Neglected Tropical Diseases|November 20, 2019
Immune responses to O-specific polysaccharide (OSP) in North American adults infected with Vibrio cholerae O1 InabaMotaher Hossain, Kamrul Islam, Meagan Kelly, et al.
Emerging Infectious Diseases|May 20, 2021
Seroprevalence of Severe Acute Respiratory Syndrome Coronavirus 2 IgG in Juba, South Sudan, 2020<sup>1</sup>Kirsten E Wiens, Pinyi Nyimol Mawien, John Rumunu, et al.
Mbio|December 22, 2016
Single-Cell Analysis of the Plasmablast Response to Vibrio cholerae Demonstrates Expansion of Cross-Reactive Memory B CellsRobert C Kauffman, Taufiqur R Bhuiyan, Rie Nakajima, et al.
Medrxiv : the Preprint Server for Health Sciences|March 24, 2021
Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Juba, South Sudan: a population-based studyKirsten E Wiens, Pinyi Nyimol Mawien, John Rumunu, et al.
IJID Regions|June 20, 2022
Seroprevalence of SARS-CoV-2 antibodies in Bangladesh related to novel coronavirus infectionTaufiqur Rahman Bhuiyan, Marjahan Akhtar, Aklima Akter, et al.
Pageof 19